LY6G6D產(chǎn)品信息
別稱:LY6G6D,lymphocyte antigen 6 family member G6D
物種:Human / Mouse / Cynomolgus / Rat
屬性:Protein / Cell
標(biāo)記:Biotin-labeled / Unconjugated
內(nèi)毒素(Endotoxin)
Less than 1.0 EU per μg by the LAL method.
純度(Purity)
>90% as determined by SDS-PAGE.
制劑(Formulation)
Lyophilized from 0.22 μm filtered solution in PBS, pH7.4 with trehalose as protectant.
Contact us for customized product form or formulation.
重構(gòu)方法(Reconstitution)
Please see Certificate of Analysis for specific instructions.
For best performance, we strongly recommend you to follow the reconstitution protocol provided in the CoA.
存儲(chǔ)(Storage)
For long term storage, the product should be stored at lyophilized state at -20°C or lower.
Please avoid repeated freeze-thaw cycles.
This product is stable after storage at:
1. -20°C to -70°C for 12 months in lyophilized state;
2. -70°C for 3 months under sterile conditions after reconstitution.
LY6G6D分子背景
LY6G6D屬于位于6號(hào)染色體上主要組織相容性復(fù)合體(MHC)III類區(qū)域的一組白細(xì)胞抗原-6(LY6)基因。LY6超家族的成員通常含有70至80個(gè)氨基酸,包括8至10個(gè)半胱氨酸。大多數(shù)LY6蛋白通過(guò)直接參與信號(hào)轉(zhuǎn)導(dǎo)的糖基磷脂酰肌醇(GPI)錨附著在細(xì)胞表面。
關(guān)鍵字: LY6G6D;LY6G6D蛋白;LY6G6D重組蛋白;LY6G6D融合蛋白;LY6G6D抗原;
百普賽斯集團(tuán)ACROBiosystems Group(股票代碼:301080)是成立于2010年的跨國(guó)生物科技公司,是為全球生物醫(yī)藥、健康產(chǎn)業(yè)領(lǐng)域提供關(guān)鍵生物試劑產(chǎn)品及解決方案的行業(yè)平臺(tái)型基石企業(yè)。2021年在創(chuàng)業(yè)板上市。百普賽斯集團(tuán)業(yè)務(wù)遍布全球,橫跨亞洲、北美洲、歐洲,在中國(guó)、美國(guó)、瑞士等12個(gè)城市設(shè)有辦公室、研發(fā)中心及生產(chǎn)基地。目前累計(jì)服務(wù)客戶超6000家,與全球Top 20醫(yī)藥企業(yè)均建立了長(zhǎng)期、穩(wěn)定的合作伙伴關(guān)系。集團(tuán)旗下?lián)碛衅放艫CROBiosystems百普賽斯、bioSeedin柏思薈、Condense Capital墾拓資本和ACRODiagnostics百斯醫(yī)學(xué)等。